It combines GIP and GLP-1 receptor activation in a single molecule
It is important to monitor for signs of hypoglycemia (low blood sugar), adjust the dosage as needed, and consider any unique medical conditions when administering semaglutide
After reviewing data submitted to the FDAs Adverse Event Reporting System between 2018 and 2024, McCall and his coauthors found that compounded GLP-1 medicines were correlated with a greater likelihood of abdominal pain, nausea, diarrhea, gallbladder inflammation, and suicidality compared to standard formulations, as well as more frequent hospitalization for those adverse effects
This may include optimizing heart failure management, treating respiratory infections, adjusting asthma or COPD medications, or addressing sleep apnea with continuous positive airway pressure (CPAP) therapy
Hanan Clinic, Chennai